🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I single center dose escalation study with an extension at ...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-11-08
Trial ID
NCT01634217
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase I trial studies the best dose and how well bendamustine works wi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2009-02-17
Trial ID
NCT00880815
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2002-01-29
Trial ID
NCT00053989
Treatments Being Tested
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1992-10
Trial ID
NCT00002515
This is a Phase II, open-label, two strata, multicenter, prospective study ...
Status
Completed
Location
H. Lee Moffitt Cancer Center
Start Date
2013-05
Trial ID
NCT01696461
Treatments Being Tested